Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krista Schleicher

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Experimental Dermatology|December 29, 2020
AJUBA: A regulator of epidermal homeostasis and cancerKrista Schleicher, Daniel Schramek
International Journal of Radiation Biology|September 8, 2016
Biological effects of tritium on fish cells in the concentration range of international drinking water standardsMarilyne Stuart, Amy Festarini, Krista Schleicher, et al.
Science (New York, N.Y.)|March 14, 2020
Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signalingSampath K Loganathan, Krista Schleicher, Ahmad Malik, et al.
Oncogene|March 1, 2018
Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcomaTimothy McKinnon, Rosemarie Venier, Marielle Yohe, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Experimental Dermatology|December 29, 2020
AJUBA: A regulator of epidermal homeostasis and cancerKrista Schleicher, Daniel Schramek
International Journal of Radiation Biology|September 8, 2016
Biological effects of tritium on fish cells in the concentration range of international drinking water standardsMarilyne Stuart, Amy Festarini, Krista Schleicher, et al.
Science (New York, N.Y.)|March 14, 2020
Rare driver mutations in head and neck squamous cell carcinomas converge on NOTCH signalingSampath K Loganathan, Krista Schleicher, Ahmad Malik, et al.
Oncogene|March 1, 2018
Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcomaTimothy McKinnon, Rosemarie Venier, Marielle Yohe, et al.
Pageof 1